Prospective, randomized, open-label, blinded-endpoint, parallel groups, multicentric clinical trial to compare the efficacy of administration of enalapril 20 mg + lercanidipine 10 mg versus enalapril 20 mg + amlodipine 5 mg on proteinuria.

Trial Profile

Prospective, randomized, open-label, blinded-endpoint, parallel groups, multicentric clinical trial to compare the efficacy of administration of enalapril 20 mg + lercanidipine 10 mg versus enalapril 20 mg + amlodipine 5 mg on proteinuria.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs Lercanidipine/enalapril (Primary) ; Amlodipine; Enalapril
  • Indications Hypertension; Kidney disorders
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms RED-LEVEL
  • Most Recent Events

    • 08 Aug 2016 Status changed from recruiting to completed.
    • 10 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top